Biostage, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Week In Review: Hua Medicine To Raise $200 Million Through Fundings And IPO For Oral Diabetes Drug
Article By: ChinaBio® Today
Saturday, January 13, 2018 6:23 PM EST
Hua Medicine of Shanghai expects to spend $200 million over the next three years on its novel oral diabetes 2 treatment, dorzagliatin. The company will raise additional capital for the effort and then IPO, possibly in Hong Kong or the US.
In this article: VRACY, BSTG, VAR, AZN, BMY, AMGN, BGNE
Exploring The Regular Insider Buying At Biostage Inc.
Article By: SuperInvestor Bulletin
Sunday, November 20, 2016 10:56 AM EST
Biostage’s share price experienced a decline back in May of this year. Since then, insider buying has been pretty steady and it has come from a variety of different insiders.
In this article: BSTG

Latest Tweets for $BSTG

No tweets yet!